The site is temporarily down due to maintenance. Sorry for the inconvenience.

The site is temporarily down due to maintenance. Sorry for the inconvenience.

Quality & Accuracy

Experience

The latest technologies

Speed ​​&
Credibility

Adventia – Duchenne and Becker muscular dystrophies

Known as: Adventia Duchenne and Becker muscular dystrophy carrier screening
SKU: GEN-AD004MG

1,340.00

Research material: buccal mucosa smear
Response time (working day): 20
The test is done on an empty stomach: no
Home call service: Yes
Country: EU

General Information

Adventia – Duchenne muscular dystrophy

Duchenne muscular dystrophy and Becker muscular dystrophy are rare inherited muscle diseases characterized by progressive muscle weakness and degeneration that leads to difficulty walking and shortens life expectancy.

Both of them are monogenic disorders

The study is performed by the MLPA method to detect small deletions and duplications.

The mutation detection rate exceeds 75%.

 

Sampling for research will be done:

  • In the regions: on Wednesday   
  • In Tbilisi: on Wednesday and/or Thursday (in the first half of the day)

Samples will be shipped on Thursday afternoons! For this, the sample must be sent to the central laboratory before 12:00 on Thursday

The taken sample is sent and the research is conducted in the laboratory of MEDICOVER Genetics in a laboratory with international accreditation.

Test results are available within 20 working days of sampling. The answer will be sent to the E-mail address of the doctor and the patient. at the post office. It is also possible to receive on-site laboratory center.

If necessary, Synevo Laboratory offers a consultation with a geneticist.  

 

Instructions for use

The sample collection and transport kit is intended for the collection, transport and storage of material required for genetic research, according to the specified procedure.

Security measures

  • For In Vitro Diagnostic Use.
  • Buccal swab collection devices are intended for single use by one person.
  • Store the kit at room temperature (15°C to 25°C). Properly stored kits are stable until the expiration date.
  • Do not use an expired kit.
  • Do not freeze collected samples.

Important information

  • The buccal mucosa sample should be collected immediately after opening the package.
  • Do not bend the swab with excessive force when collecting a patient sample, as this may cause the swab to break.
  • 30 minutes before sample collection, the patient is prohibited from: smoking, taking food and liquids (except water), brushing teeth and chewing gum
  • Please follow the instructions for specimen labelling, collection and transport carefully.
  • Check that all patient identification data is correct and compliant before specimen packaging and shipping

 

Product content

 

Sample collection Device: Two (2) buccal swab collection devices

 

 

Packaging materials: One (1) biosecurity bag to seal the specimen

 

 

Documentation:

  1. One (1) barcode card with three (3) labels
  2. Sample fill-in form with QR code on buffered envelope
  3. Informed consent – ​​in a sample form

 

 

Sample collection instructions

 

  1. Fill out the sample form. A completed and signed copy of the form must be sent with the sample.
  2. Complete the patient's first and last name on the barcode label ending with BS1 and BS2 and affix it to the cheek swab collection device. Attach the remaining barcode label to the form to be filled.
  3. Using gloves, open the pouch and remove the buccal swab collection device.
  4. To easily open the cap of the tube, hold the swab of the plastic tube with one hand and press the white cap with your thumb.
  5. Hold the swab by the handle (white cap), remove the swab from the plastic tube and place the tube on a clean surface.
  6. Place the swab in your mouth on your tongue and wet it with saliva for ten seconds.
  7. Move the swab on one side of the mouth between the cheek and gums in an up-down direction for 10 seconds. At the same time, massage the outside of the cheek with the other hand to increase the friction of the tampon with the mucous membrane.
  8. Repeat the sequence of point 7 on the other side of the mouth.
  9. After taking the sample, put the swab back into the plastic tube and close it securely.
  10. Place the sample in a biosafety bag and seal securely. Repeat the same procedure with the smear sample of the other cheek.
  11. Place the sealed bag in a buffered envelope.
  12. Remove the cover from the adhesive strip of the envelope and seal the envelope

 

Order details and support

For assistance or to order additional kits, please call +(995)32 2 800 111 or email us at info@synevo.ge. Additional information is available online at Synevo.ge

Product description

What is Advent?

Adventia is a new generation genetic test that determines whether a phenotypically healthy person is a carrier of a genetic disease.

Adventia allows diagnostics of autosomal and X-linked recessive disease. Carriers of recessive diseases have one healthy gene and one gene with a mutation.

The information obtained from the Adventia genetic test helps us make reproductive decisions and minimizes the number of people who can pass on genetic diseases to their offspring.

 

When is the survey conducted?

Any person can be a carrier of this or that mutation (mutation – permanent change in the nucleotide sequence of DNA). Some mutations have no effect on human health, while others cause genetic diseases.

When a person is a carrier of a specific gene mutation, but this mutation is not strong enough to cause the disease to manifest in the individual - this is a recessive gene carrier for the disease. If both parents carry the same gene mutation and their child inherits the mutation from both of them, the child will be affected.

Carrying a recessive gene mutation is asymptomatic, therefore the individual has no information about the risk of passing this mutation on to the offspring.

A number of recessive disease genes may be transmitted from generation to generation without symptoms.

Early knowledge of carrier status and the risk of passing on genetic disorders to children makes it possible to:

  • Making appropriate decisions by assessing the patient's reproductive risks
  • Organization of early intervention and treatment - in cases where the developed disease allows for this.
  • Optimizing the clinical management of the sick child

 

According to the recommendation of international organizations, information about pregnancy screening should be available to all pregnant women; Simultaneous screening for multiple conditions is recommended.

 

Who is it for? intended for Adventia?

  • For couples who are planning to start a family and want to have information about their pregnancy status.
  • For any individual or couple seeking Assisted Reproductive Technologies, including In Vitro Fertilization.
  • For sperm and egg donors and recipients.
  • For couples who are expecting a child and want to know if their child is at risk of a genetic disorder
  • For population groups at high risk of specific disorders
  • For people with a family history of genetic mutations
  • For anyone who wants to know more about their genetic profile

Testing process

Purchase a test Submission of material

Purchase a test

Submission of material

Results Online Consult a doctor

Results Online

Consult a doctor

Resources

https://medicover-genetics.com/our-genetic-tests/reproductive-health/carrier-screening/

  1. Lazarin, Gabriel A., et al. "Systematic Classification of Disease Severity for Evaluation of Expanded Carrier Screening Panels." PLoS ONE, vol. 9, no. 12, 2014
  2. American College of Obstetricians and Gynecologists "Committee Opinion No. 691: Carrier Screening for Genetic Conditions.” Obstetrics & Gynecology, vol. 129, no. 3, 2017
  3. Edwards, Janice G., et al. "Expanded Carrier Screening in Reproductive Medicine—Points to Consider." Obstetrics & Gynecology, vol. 125, no. 3, 2015, pp. 653–662
  4. Gregg, Anthony R., et al. "Screening for Autosomal Recessive and X-Linked Conditions During Pregnancy and Preconception: A Practice Resource of the American College of Medical Genetics and Genomics (ACMG)." Genetics in Medicine, vol. 23, no. 10, 2021, pp. 1793–1806
Laboratories
Call Now Button